95200 ⎘
Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems; Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring Oxygen atoms
SUBSTITUTED BENZOFURAN, BENZOPYRROLE, BENZOTHIOPHENE, AND STRUCTURALLY RELATED COMPLEMENT INHIBITORS
#2STING AGONIST COMPOUNDS
#3SIMMPYRAs: Novel Drugs for Triple Negative Breast Cancer
#4TETRALIN AND TETRAHYDROQUINOLINE COMPOUNDS AS INHIBITORS OF HIF-2ALPHA
#5INHIBITORS OF THE ONCOGENIC SHP2 PHOSPHATASE AND USES THEREOF
#6ESTROGEN RECEPTOR-MODULATING COMPOUNDS
#7SUBSTITUTED BENZOFURAN, BENZOPYRROLE, BENZOTHIOPHENE, AND STRUCTURALLY RELATED COMPLEMENT INHIBITORS
#8Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha
#9ARYLAMIDES AND METHODS OF USE THEREOF
#10Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors
#11Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors
#12Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha
#13Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors
#14Estrogen receptor-modulating compounds
#15Benzothiophene-based selective estrogen receptor downregulator compounds
#16Fluorine-containing substituted benzothiophene compound, and pharmaceutical composition and application thereof
#172,3-dihydrobenzo[b]thiophene derivatives as hypoxia inducible factor-2(alpha) inhibitors
#18Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2α
#19Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors
#20BENZOTHIOPHENE ESTROGEN RECEPTOR MODULATORS TO TREAT MEDICAL DISORDERS
#21Antiestrogen compounds
#22Benzothiophene-based selective estrogen receptor downregulators
#23RADIOTRACERS FOR IMAGING ER-POSITIVE BREAST CANCER
#24Estrogen receptor-modulating compounds
#25Reaction medium containing water-surfactant mixture
#26Benzothiophene estrogen receptor modulators
#27Benzothiophene-based selective estrogen receptor downregulator compounds
#28Benzothiophene-based selective estrogen receptor downregulators
#29Hydrophobic compounds for optically active devices
#30Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors
#31RADIOTRACERS FOR IMAGING ER-POSITIVE BREAST CANCER
#32Benzothiophene estrogen receptor modulators
#33Compositions and methods for treating estrogen-related medical disorders
#34Benzothiophene-based selective estrogen receptor downregulators
#35LIQUID CRYSTAL COMPOUND HAVING BENZOTHIOPHENE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE
#36Benzothiophene estrogen receptor modulators
#37Compositions and methods for treating estrogen-related medical disorders
#38Benzothiophene derivatives and compositions thereof as selective estrogen receptor degraders
#39Liquid crystal compound having benzothiophene, liquid crystal composition and liquid crystal display device
#40BENZOTHIOPHENE-BASED SELECTIVE ESTROGEN RECEPTOR DOWNREGULATOR COMPOUNDS
#41Benzothiophene-based selective estrogen receptor downregulators
#42STAT3 inhibitor
#43Compositions and methods for treating estrogen-related medical disorders
#44Benzothiophene derivatives and compositions thereof as selective estrogen receptor degraders
#45Cyclic sulfone and sulfoximine analogs and uses thereof
#46Benzothiophene derivatives and compositions thereof as selective estrogen receptor degraders
#475,6-dimethoxy-1,1-dioxobenzo[b]thiophene-2-methyloxycarbonyl (DM-Bsmoc) and related amino-protecting groups
#48Chiral compounds, compositions, products and methods employing same
#49Benzothiophene derivatives and compositions thereof as selective estrogen receptor degraders
#50STAT3 inhibitor
#51Compositions and methods for treating estrogen-related medical disorders
#52COMPOSITIONS AND METHODS FOR TREATING ESTROGEN-RELATED MEDICAL DISORDERS
#53Aromatic ring compound
#54Compounds and compositions as selective estrogen receptor degraders
#55N-arylaminomethylene benzothiophenones for treatment of cardiovascular disease
#56SKIN LIGHTENING COMPOSITIONS
#57Chiral compounds, compositions, products and methods employing same
#58ANTI-NEURODEGENERATIVE DISEASE AGENT
#59Phenoxy acetic acid derivatives
#60Process for production of 1-(3-(2-(1-benzothiophen-5-yl)-ethoxy)propyl)azetidin-3-ol or salts thereof
#61Broad spectrum gram-positive antimicrobials and anthelmintics with efficacy against drug-resistant strains and species
#62Therapeutic compounds
#63Sulphonium salt initiators
#64PRODRUG DERIVATIVES OF ACIDS USING ALCOHOLS WITH HOMOTOPIC HYDROXY GROUPS AND METHODS FOR THEIR PREPARATION AND USE
#65Process and intermediates for preparing arzoxifene
#66BENZO[b]THIOPHEN DERIVATIVES AND PROCESS FOR THEIR PRODUCTION
#67CXCR2 inhibitors
#68Non-Peptidic Inhibitors of AKAP/PKA Interaction
#69Internally Masked Neopentyl Sulfonyl Ester Cyclization Release Prodrugs of Acamprosate, Compositions Thereof, and Methods of Use
#70Process for production of 1-(3-(2-(1-benzothiophen-5-yl)-ethoxy)propyl)azetidin-3-ol or salts thereof
#71DEUTERIUM-ENRICHED AROXIFENE
#72Selective Estrogen Receptor Modulators
#73Selective estrogen receptor modulators containing a phenylsulfonyl group
#74Indazole compounds as B3 adrenoceptor agonist
#75Indazole compounds as β3 andrenoceptor agonist
#76Prodrug derivatives of acids using alcohols with homotopic hydroxy groups and methods for their preparation and use
#77Dihydrobenzothiophenes
#78Selective estrogen receptor modulators
#79Benzofurans and benzothiophenes
#80Selective estrogen receptor modulators
#81Pentalfluoroalkanesulfinyl naphthalenes and related estrogen receptor modulators
#82Process for preparing 3,3-disubstituted oxindoles and thio-oxindoles
#83Selective estrogen receptor modulators containing a phenylsulfonyl group
#84Tubulin binding agents and corresponding prodrug constructs
#851,2,4-Triaminobenzene derivatives useful for treating disorders of the central nervous system
#86Heterocyclic compound having oxime group
#87Synthesis for the preparation of compounds for screening as potential tubulin binding agents
#88Information recording medium and oxonol compound
#89Indazole compounds as β3 adrenoceptor agonist